| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2483.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Buck Institute for Age Research, Novato, Calif (Y.Z., Y.S., L.X., K.J., D.A.G.), and Department of Pharmacology and Ophthalmology and Visual Sciences, University of Wisconsin, Madison (N.S.).
Correspondence to David A. Greenberg, MD, PhD, Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945. E-mail dgreenberg{at}buckinstitute.org
Background and Purpose Endoglin (CD105) is a membrane glycoprotein that is mutated in hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and shows increased expression in proliferating endothelial cells during angiogenesis.
Methods We investigated the effect of hypoxia on endoglin expression in murine cerebral microvascular endothelial (bEND.3) cells in vitro and the possible involvement of mitogen-activated protein kinase (MAPK) pathways.
Results Hypoxia increased endoglin mRNA and protein expression in bEND.3 cells, which was associated with phosphoactivation of extracellular signalrelated kinase (ERK), p38 MAPK, and Jun amino-terminal kinase (JNK). Inhibitors of p38 decreased hypoxic induction of endoglin expression, as did dominant negative MAPK kinase 3 (MKK3), which activates p38. In contrast, constitutively active MKK3 or JNK1 potentiated the hypoxic induction of endoglin.
Conclusions These results indicate that hypoxia induces the expression of endoglin at both the mRNA and protein levels and that induction is regulated by the p38 and perhaps also JNK pathways.
Key Words: angiogenesis brain endoglin endothelium hypoxia mitogen-activated protein kinases protein kinases
This article has been cited by other articles:
![]() |
N. A. Dallas, S. Samuel, L. Xia, F. Fan, M. J. Gray, S. J. Lim, and L. M. Ellis Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy Clin. Cancer Res., April 1, 2008; 14(7): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yinon, O. Nevo, J. Xu, A. Many, A. Rolfo, T. Todros, M. Post, and I. Caniggia Severe Intrauterine Growth Restriction Pregnancies Have Increased Placental Endoglin Levels: Hypoxic Regulation via Transforming Growth Factor- 3 Am. J. Pathol., January 1, 2008; 172(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muenzner, M. Rohde, S. Kneitz, and C. R. Hauck CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells J. Cell Biol., August 29, 2005; 170(5): 825 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, D. Hammaker, D. L. Boyle, and G. S. Firestein Regulation of p38 MAPK by MAPK Kinases 3 and 6 in Fibroblast-Like Synoviocytes J. Immunol., April 1, 2005; 174(7): 4301 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Guo, S. Kumar, C. Li, M. Slevin, and P. Kumar CD105 (Endoglin), Apoptosis, and Stroke Stroke, May 1, 2004; 35(5): e94 - e95. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |